Clinical trial Recruiting at 1 site Interventional Ages 8 to 12

Combining training programs for children with ADHD and their parents

Official title: Evaluating the Efficacy of Sequenced Central Executive and Behavioral Parent Training for Children With ADHD

Run by Florida State University · NCT05492422 · Data updated 2026-11-12

This study tests whether combining a memory training program for kids with ADHD and a parenting program can help improve their symptoms and family relationships.

Quick facts

Study typeInterventional
Ages8 Years to 12 Years
SexAll
Enrollment200 (estimated)
SponsorFlorida State University
Academic / other
Locations1 site (Tallahassee, Florida)
StatusRecruiting
StartedOctober 3, 2022
Main results expectedAugust 1, 2027
Study endsAugust 1, 2027
Registry record updatedMay 7, 2026
Trial IDNCT05492422 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 8-12 with a principal diagnosis of ADHD and elevated ADHD symptoms as reported by parents and teachers.

Probably not a fit

Patients with severe neurological impairments, significant psychiatric disorders, or those who do not speak English may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to integrate two evidence-based treatments for school-aged children diagnosed with ADHD: Central Executive Training (CET) and Behavioral Parent Training (BPT). CET is a computerized intervention designed to enhance children's working memory and alleviate ADHD symptoms, while BPT focuses on improving family dynamics and reducing oppositional-defiant behaviors by modifying parenting strategies. The study hypothesizes that delivering CET prior to BPT will yield complementary benefits for the children and their families. The effectiveness of this combined approach will be evaluated through various assessments of ADHD symptoms and family functioning.

Why it matters

Potential benefit: If successful, this approach could significantly improve ADHD symptoms and family relationships for affected children and their parents.

How similar studies have gone: Previous studies have shown promise in using combined behavioral interventions for ADHD, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion:

1. Children ages 8-12 with principal ADHD diagnoses (via K-SADS); and
2. parent AND teacher ratings in clinical/borderline range based on age and sex on ADHD Rating Scale (ADHD-5) or Behavior Assessment Scale for Children (BASC-3) Attention Problems/Hyperactivity subscales (i.e., 90th percentile or higher based on both informants).

All DSM-5 ADHD presentations will be eligible.

Exclusion:

1. gross neurological, sensory, or motor impairment;
2. history of seizure disorder, psychosis, bipolar, or severe dysregulation disorders that may interfere with participation (e.g., disruptive mood dysregulation, intermittent explosive, reactive attachment, substance use);
3. intellectual disability or Wechsler Intelligence Scale for Children (WISC-V) short-form standard score \<70;
4. conditions requiring acute intervention, e.g., active suicidality; and
5. non-English speaking child or parent.

Where it's running

  • Florida State University
    Tallahassee, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.